$MCRB Seres Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Seres Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seres Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Seres Therapeutics, Inc. for free.
CIK Number: 0001609809
IRS Number: 274326290
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MCRB
Company Address: 200 SIDNEY STREET CAMBRIDGE 02139
Phone number: 617 945 9626
Former name: Newco LS21, Inc.
Former name: Seres Health, Inc., date of change: 2014-06-03
Market Capitalization: $374.90M
Prev close: $9.50
Average Daily Volume: 233,558
Days Low: $9.22
Year Low: $8.05
Year High: $35.98
Seres Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | MCRB | Seres Therapeutics ... | Nutritional Health LTP Fund Ge ... | 10% Owner | Sell | J | 0.00 | 295,171 | 0 | 2,962,963 | 3.3 M to 3 M (-9.06 %) |
Feb 08 2021 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 26.34 | 100,000 | 2,634,000 | 100,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | Chapman Marcus | See Remarks | Option Exercise | A | 26.34 | 24,000 | 632,160 | 24,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | Chapman Marcus | See Remarks | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | von Moltke Lisa | See Remarks | Option Exercise | A | 26.34 | 110,000 | 2,897,400 | 110,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | Young Teresa L. | See Remarks | Option Exercise | A | 26.34 | 90,000 | 2,370,600 | 90,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | Shaff Eric D. | President, CEO | Option Exercise | A | 26.34 | 350,000 | 9,219,000 | 350,000 | |
Feb 08 2021 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Option Exercise | A | 26.34 | 130,000 | 3,424,200 | 130,000 | |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Option Exercise | M | 6.01 | 27,562 | 165,648 | 45,938 | |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Option Exercise | M | 9.89 | 26,250 | 259,613 | 3,750 | |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Option Exercise | M | 0.71 | 26,000 | 18,460 | 0 | |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Sell | S | 28.34 | 9,841 | 278,894 | 0 | 9.8 K to 0 (-100.00 %) |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Sell | S | 27.56 | 26,265 | 723,863 | 9,841 | 36.1 K to 9.8 K (-72.74 %) |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Sell | S | 26.56 | 55,706 | 1,479,551 | 36,106 | 91.8 K to 36.1 K (-60.67 %) |
Dec 03 2020 | MCRB | Seres Therapeutics ... | Henn Matthew R. | See Remarks | Buy | M | 6.01 | 27,562 | 165,648 | 91,812 | 64.3 K to 91.8 K (+42.90 %) |